(Q40047909)

English

p73 expression modulates p63 and Mdm2 protein presence in complex with p53 family-specific DNA target sequence in squamous cell carcinogenesis

scientific article published on 19 November 2007

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

p73 expression modulates p63 and Mdm2 protein presence in complex with p53 family-specific DNA target sequence in squamous cell carcinogenesis (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

1 reference

based on heuristic

inferred from title

author name string

J Johnson

1

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

J Lagowski

2

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

S Lawson

3

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Y Liu

4

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

M Kulesz-Martin

5

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

language of work or name

0 references

publication date

19 November 2007

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

2780-2787

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

p73 transcriptional activity increases upon cooperation between its spliced forms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210941

21 January 2018

p53 isoforms can regulate p53 transcriptional activity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210941

21 January 2018

Post-prandial hyperglycemia is an important predictor of the incidence of diabetic microangiopathy in Japanese type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210941

21 January 2018

p63 and p73 in human cancer: defining the network

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210941

21 January 2018

Tumor-specific p73 up-regulation mediates p63 dependence in squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210941

21 January 2018

p63alpha and DeltaNp63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210941

21 January 2018

Complex transcriptional effects of p63 isoforms: identification of novel activation and repression domains

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210941

21 January 2018

When p53 needs p73 to be functional - forced p73 expression induces nuclear accumulation of endogenous p53 protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210941

21 January 2018

p53: 25 years after its discovery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210941

21 January 2018

MDMX overexpression prevents p53 activation by the MDM2 inhibitor Nutlin.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210941

21 January 2018

Role of the newer p53 family proteins in malignancy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210941

21 January 2018

MDM2 inhibits PCAF (p300/CREB-binding protein-associated factor)-mediated p53 acetylation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210941

21 January 2018

p73 loss triggers conversion to squamous cell carcinoma reversible upon reconstitution with TAp73alpha.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210941

21 January 2018

Regulation of p63 function by Mdm2 and MdmX.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210941

21 January 2018

Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210941

21 January 2018

Unique domain functions of p63 isotypes that differentially regulate distinct aspects of epidermal homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210941

21 January 2018

Defective p53 post-translational modification required for wild type p53 inactivation in malignant epithelial cells with mdm2 gene amplification

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210941

21 January 2018

Mutation and cancer: statistical study of retinoblastoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210941

21 January 2018

The C-terminal sterile alpha motif and the extreme C terminus regulate the transcriptional activity of the alpha isoform of p73.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210941

21 January 2018

DeltaNp73beta is active in transactivation and growth suppression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210941

21 January 2018

p73: Friend or foe in tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210941

21 January 2018

The p53 and Mdm2 families in cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210941

21 January 2018

Association of p63 with proliferative potential in normal and neoplastic human keratinocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210941

21 January 2018

p63 and p73: life and death in squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210941

21 January 2018

In vivo activation of the p53 pathway by small-molecule antagonists of MDM2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210941

21 January 2018

Activities and response to DNA damage of latent and active sequence-specific DNA binding forms of mouse p53

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210941

21 January 2018

p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210941

21 January 2018

MDM2 suppresses p73 function without promoting p73 degradation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210941

21 January 2018

Activation of p53 by MDM2 antagonists can protect proliferating cells from mitotic inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210941

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210941

7 January 2021

based on heuristic

inferred from DOI database lookup

Benign and malignant tumor stages in a mouse keratinocyte line treated with 7,12-dimethylbenz[a]anthracene in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210941

7 January 2021

based on heuristic

inferred from DOI database lookup

Facilitated search for specific genomic targets by p53 C-terminal basic DNA binding domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210941

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.ONC.1210941

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40047909&oldid=2217742082"